TY  - JOUR
AU  - Alten, Rieke
AU  - Mariette, Xavier
AU  - Lorenz, Hanns-Martin
AU  - Nüßlein, Hubert
AU  - Galeazzi, Mauro
AU  - Navarro, Federico
AU  - Chartier, Melanie
AU  - Heitzmann, Julia
AU  - Poncet, Coralie
AU  - Rauch, Christiane
AU  - Le Bars, Manuela
PY  - 2019
DO  - 10.1007/s10067-019-04449-w
UR  - http://hdl.handle.net/10668/13603
T2  - Clinical rheumatology
AB  - Evaluate abatacept retention over 2 years in the AbataCepT In rOutiNe clinical practice (ACTION) study. ACTION was an international, observational study of patients with moderate-to-severe rheumatoid arthritis (RA) who initiated intravenous abatacept....
LA  - en
KW  - Biologic
KW  - Efficacy
KW  - Predictor
KW  - Remission
KW  - Rheumatoid arthritis
KW  - Abatacept
KW  - Adrenal Cortex Hormones
KW  - Aged
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - Cohort Studies
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Internationality
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Proportional Hazards Models
KW  - Rheumatoid Factor
KW  - Treatment Outcome
TI  - Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study.
TY  - research article
VL  - 38
ER  -